Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
ANTIBIOTIC PROFILE OF BURKHOLDERIA CEPACIA IN TERTIARY CARE HOSPITAL, VADODARA, GUJARAT, INDIA.
View through CrossRef
Since the early 1980's, Burkholderia cepacia is emerged as a causative agent of opportunistic human infections.
Burkholderia cepacia (B. cepacia) is an opportunistic pathogen which causes severe infections in patients with underlying
diseases, such as cystic brosis (CF) or chronic granulomatous disease (CGD). B. cepacia causes nosocomial bloodstream infections in non-CF
patients with a mortality rate of 25%–64%. Several severe infections caused by B. cepacia have been reported in children e.g. sepsis, pneumonia,
CNS infections, and urinary tract infections. This prospective analysis was done in tertiary care hospital in Vadodara during the period of January -
June 2023. 17 non-duplicate Burkholderia cepacia were recovered from samples. Out of 17 Burkholderia cepacia isolates, 12 isolates are most
sensitive to Meropenem (70.59%), Ceftazidime (52.94%), Trimethoprim/Sulphamethoxazole (47.06%), Cefoperazone/ Sulbactam (29.41%),
Imipenem (23.53%), Minocyclin (23.53%), Piperacillin/Tazobactam (17.65%), Cefepime (17.65%), Ciprooxacin (17.65%), Levooxacin
(17.65%), Aztreonam (5.88%) and, Tigecycline (0%).
Title: ANTIBIOTIC PROFILE OF BURKHOLDERIA CEPACIA IN TERTIARY CARE HOSPITAL, VADODARA, GUJARAT, INDIA.
Description:
Since the early 1980's, Burkholderia cepacia is emerged as a causative agent of opportunistic human infections.
Burkholderia cepacia (B.
cepacia) is an opportunistic pathogen which causes severe infections in patients with underlying
diseases, such as cystic brosis (CF) or chronic granulomatous disease (CGD).
B.
cepacia causes nosocomial bloodstream infections in non-CF
patients with a mortality rate of 25%–64%.
Several severe infections caused by B.
cepacia have been reported in children e.
g.
sepsis, pneumonia,
CNS infections, and urinary tract infections.
This prospective analysis was done in tertiary care hospital in Vadodara during the period of January -
June 2023.
17 non-duplicate Burkholderia cepacia were recovered from samples.
Out of 17 Burkholderia cepacia isolates, 12 isolates are most
sensitive to Meropenem (70.
59%), Ceftazidime (52.
94%), Trimethoprim/Sulphamethoxazole (47.
06%), Cefoperazone/ Sulbactam (29.
41%),
Imipenem (23.
53%), Minocyclin (23.
53%), Piperacillin/Tazobactam (17.
65%), Cefepime (17.
65%), Ciprooxacin (17.
65%), Levooxacin
(17.
65%), Aztreonam (5.
88%) and, Tigecycline (0%).
Related Results
Identification and Population Structure of
Burkholderia stabilis
sp. nov. (formerly
Burkholderia cepacia
Genomovar IV)
Identification and Population Structure of
Burkholderia stabilis
sp. nov. (formerly
Burkholderia cepacia
Genomovar IV)
ABSTRACT
The
Burkholderia cepacia
complex currently comprises five genomic species, i.e.,
B. cepacia
genomova...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with
Burkholderia cepacia
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with
Burkholderia cepacia
Abstract
Most Burkholderia cepacia strains are resistant to many, or all, of the antibacterial agents commonly used in cystic fibrosis (CF), and selection of appr...
Novel Class 1 Integron in Clinical Isolates of
Burkholderia cepacia
Complex
Novel Class 1 Integron in Clinical Isolates of
Burkholderia cepacia
Complex
Objectives
The potent nosocomial pathogens,
Burkholderia cepacia
complex (BCC), comprise a gr...
Current and Future Trends for COVID-19: A Case Study of Vadodara, India
Current and Future Trends for COVID-19: A Case Study of Vadodara, India
Background: COVID-19 has been a pandemic and global disaster since the beginning of 2020. However, there is a lack of city/locale based studies on status and trends of COVID-19 in ...
Isolation and characterization of bacteriophages against Burkholderia species
Isolation and characterization of bacteriophages against Burkholderia species
Abstract
Burkholderia cepacia complex (Bcc) is a potent nosocomial pathogen mainly encountered in immunocompromised, cystic fibrosis and chronic granulomatous patients. The...
The prevalence and antibiotics resistance profile of
Burkholderia cepacia
in neonatal sepsis: a pioneer study in Kurdistan Region-Iraq
The prevalence and antibiotics resistance profile of
Burkholderia cepacia
in neonatal sepsis: a pioneer study in Kurdistan Region-Iraq
Abstract
Burkholderia cepacia (B. cepacia) is Gram-negative, multidrug-resistant bacteria that can infect neonates and hospitalized patients, often spreading thro...
Sequence and Structure-Based Classification of PenA β-Lactamase from Burkholderia stabilis
Sequence and Structure-Based Classification of PenA β-Lactamase from Burkholderia stabilis
The process of hydrolysis of the bond between amides of the four-membered β-lactam ring in Gram-negative bacteria is the key mechanism of resistance in β-lactamase enzymes. Because...